| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f21c1385a21bf8adde87df2835fb5bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f540ff0f86fe08ac330be6b4199b97d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8754bbff99838418ceabedd9eddb5395 |
| publicationDate |
2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110115760-A |
| titleOfInvention |
A kind of flavin containing monooxygenase 2 is preparing the application in angiogenesis promotor |
| abstract |
The invention discloses a kind of flavin containing monooxygenases 2 to prepare the application in angiogenesis promotor, and the present invention is handled by doing FMO2 overexpression to heart infarction model, show FMO2 have promote heart infarction after angiogenesis ability. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022037070-A1 |
| priorityDate |
2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |